Results 51 to 60 of about 236,531 (317)
Journal of Clinical Endocrinology and MetabolismCONTEXT The effect of testosterone on depressive symptoms in men with hypogonadism remains incompletely understood. OBJECTIVE We assessed the effects of testosterone replacement therapy (TRT) in improving depressive symptoms in hypogonadal men with and
Shalender Bhasin +10 more
semanticscholar +1 more source
F&S Reviews, 2020 Testosterone replacement therapy is an important treatment option for men with low testosterone and symptomatic hypogonadism. Various formulations of exogenous testosterone replacement therapy exist, including oral, buccal, intramuscular, transdermal ...
K. Khodamoradi +5 more
semanticscholar +1 more source
Testosterone replacement therapy and voiding dysfunction [PDF]
Translational Andrology and Urology, 2016 Testosterone replacement therapy (TRT) represents an increasing popular treatment option for men with late-onset hypogonadism (LOH). Because of unsubstantiated beliefs of testosterone's effect on the prostate, the FDA has recently placed a warning on testosterone products, stating that TRT may worsen benign prostatic hyperplasia (BPH).
Baas, Wesley, Köhler, Tobias S.
openaire +2 more sources
Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? [PDF]
, 2003 BACKGROUND Conventional hormone replacement therapy (HRT) containing conjugated equine oestrogen (CEE) and medroxyprogesterone acetate (MPA) increases triglyceride, C- reactive protein (CRP) and coagulation Factor VII concentrations, potentially ...
Alan J. Jaap +46 more
core +1 more source
Andrology, 2020 Low testosterone (T) level is considered a marker of poor cardiovascular health. Ten years ago, the Testosterone in Older Men with Mobility Limitations (TOM) trial was discontinued due to a higher number of adverse events in men receiving T compared with
F. Sesti +5 more
semanticscholar +1 more source
Testosterone Deficiency, Cardiac Health, and Older Men
International Journal of Endocrinology, 2014 Low levels of testosterone are manifested by erectile dysfunction, reduced sexual desire, and loss of morning erections with increasing numbers of men are being diagnosed and require treatment.
G. Hackett, M. Kirby, A. J. Sinclair
doaj +1 more source
Frontiers in Reproductive Health, 2023 Obstructive sleep apnoea syndrome (OSAS) is an under-recognized medical disease. The main risk factors for OSAS are male sex, older age, obesity, and metabolic syndrome, that are also associated with male hypogonadism (MH).
Andrea Graziani +2 more
doaj +1 more source
The unsolved case of “bone-impairing analgesics”. The endocrine effects of opioids on bone metabolism [PDF]
, 2015 The current literature describes the possible risks for bone fracture in chronic analgesics users. There are three main hypotheses that could explain the increased risk of fracture associated with central analgesics, such as opioids: 1) the increased ...
COLUZZI, FLAMINIA +3 more
core +3 more sources
Geriatrics, 2020 Background. Epidemiological data report that male hypogonadism may play a role in cognitive impairment in elderly. However, the effect of testosterone replacement therapy (TRT) on cognitive abilities in this cluster of patients has not been well ...
G. Lisco +5 more
semanticscholar +1 more source
Pharmacology of testosterone replacement therapy preparations [PDF]
Translational Andrology and Urology, 2016 The goal of testosterone replacement therapy (TRT) is to return serum testosterone levels to within physiologic range and improve symptoms in hypogonadal men. Some of the symptoms aimed to improve upon include decreased libido, erectile dysfunction, infertility, hot flashes, depressed mood, and loss of muscle mass or hair.
Shoskes, Jennifer J. +2 more
openaire +2 more sources